Market research
IBX.AU Imagion Biosystems Limited
AU AUD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 8M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- -0.2
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- AU000000IBX6
- Market cap
- 8M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- -0.2
About
About Imagion Biosystems Limited
Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the IBX.AU discussion.
5 years, 4 months ago
Imagion Biosystems Limited is currently in a long term downtrend where the price is trading 32.0% below its 200 day moving average.
From a valuation standpoint, the stock is 111.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 544.7.
Imagion Biosystems Limited's total revenue rose by 191.1% to $384K since the same quarter in the previous year.
Its net income has dropped by 48.2% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 204.6% to $-2M since the same quarter in the previous year.
Based on the above factors, Imagion Biosystems Limited gets an overall score of 1/5.